Interests
Health economics, financing, policy and strategy development and systems development.Skills
Strategy and policy analysis, performance monitoring, independent evaluation and review, economic and financial analysis, organisational development, research and analysis, facilitation, and project managementBackground and relevant experience
Matthew is an experienced health economist and global health specialist. He works in a range of capacities as a researcher, consultant and evaluator.Matthew is adept at supporting the development and review of organisational, programmatic and investment strategies/policies, including donor country strategies, resource mobilisation strategies and work plans; resource tracking; preparation of investment cases and briefs to influence policy; monitoring and evaluation (M&E), including programme evaluations, designing M&E frameworks, and cost-effectiveness and value for money (VfM) analyses; analysing market dynamics issues for commodities and developing sustainable market-based approaches; and provision of technical assistance and capacity building.
Matthew has worked extensively with Gavi and the Global Fund, as well as with the ELMA Foundation, UK Foreign and Commonwealth Development Office (FCDO), Gates Foundation, Medicines Patent Pool (MPP), Partnership for Maternal, Newborn and Child Health (PMNCH), Public Health England, Stop TB Partnership, TB REACH, UNICEF, UNITAID, Wellcome Trust and WHO.
Indicative examples of Matthew’s work in recent years include:
- Evaluation of the operationalisation of Gavi’s strategy through Gavi’s policies, programmatic guidance and use of funding levers (2023)
- Development of ToCs and M&E approaches for Wellcome Trust and Gavi (2021-23)
- WHO and UNAIDS evaluations on their work towards Primary Health Care (PHC; 2023)
- UK FCDO design of Future Health Investment Strategy in Nepal (2022):
- Global Fund regional and country analysis of domestic budgeting and spending in Africa and the Middle East (2022)
- Gavi evaluation of the COVAX Facility and AMC (2022)
- Global Fund evaluations of Strategic Initiatives and Multi-Country Catalytic Investments (2021)
- UK FCDO evaluation of the Prosperity Fund Better Health Programme (2019-21).
- Evaluation of PHE Public Health Rapid Support Team (2019-21).
- Evaluation of PHE International Health Regulations Strengthening Project (2019-21).
- Global Fund Strategic Review 2020 (2020).
- VfM assessment of the Millennium Development Goal Initiative: Accelerating progress towards maternal, neonatal and child morbidity and mortality reduction in Zambia (2020).
- Thematic review of the Global Fund Sustainability, Transition and Co-financing Policy (STC) (2019).
- Evaluation of Gavi’s Gender Policy (2018-19).
- Evaluation of Gavi’s support to CSOs (2018).
- Global Fund Prospective Country Evaluations (PCE; 2017-20).
- Global Fund Strategic Review 2017 (2017).
- Evaluation of UNICEF’s PMTCT and paediatric HIV/AIDS programme (2016).
- Gates Foundation rapid assessment of the comprehensive Multi-Year Planning (cMYP) process in multiple countries (2016-17).
- Mid-term review of the UNITAID Improving Severe Malaria Outcomes project (2015).
- Evaluation of UNITAID’s grant to TB REACH for the procurement of GeneXpert machines (2015).
- WHO development of an investment case for CRVS systems in Mozambique, Bangladesh and Kenya (2014).
- HMN Development of an investment case for CRVS systems (2012).
- Gavi strategic consultancy on organisational approach to earmarked funding (2011/12).
- Gavi evaluation of the IFFIm (2010/11).